Nevada Cannabis: Federal Rescheduling Rewrites the Future
The federal government has executed its most significant maneuver in drug policy since the Controlled Substances Act of 1970. On April 23, 2026, the U.S. Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) finalized an order reclassifying state-licensed medical marijuana products—alongside FDA-approved cannabis drugs—from Schedule I to Schedule III. For Nevada’s robust cannabis…

